Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong · Delayed Price · Currency is HKD 3.600
-0.020 (-0.55%)
Oct 9, 2026, 4:08 PM HKT
HKG:2591 Market Cap
HKG:2591 has a market cap or net worth of 1.64 billion as of October 9, 2026. It is the 20,644th most valuable company in the world and the 943rd biggest in Hong Kong. Its market cap has decreased by 90.89% in one year.
Market Cap
1.64B
Enterprise Value
638.27M
Revenue
176.96M
Global Rank
Country Rank
#943 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since August 15, 2025, HKG:2591's market cap has decreased from 26.15B to 1.64B, a decrease of -93.71%. That is a compound annual growth rate of -90.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 1.64B | -88.25% |
| Dec 31, 2025 | 14.00B | -46.48% |
| Aug 15, 2025 | 26.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Antengene Corporation | 2.19B |
| Mabpharm | 2.08B |
| HighTide Therapeutics | 1.96B |
| Shandong Boan Biotechnology | 1.93B |
| PegBio | 1.83B |
| Beijing Biostar Pharmaceuticals | 1.68B |
| SinoMab BioScience | 1.59B |
| TYK Medicines | 1.36B |